Pierantonio Menna Selected Research

ferrylmyoglobin

2/2004	Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin.
9/2002	Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierantonio Menna Research Topics

Disease

30	Cardiotoxicity 01/2022 - 09/2002
19	Neoplasms (Cancer) 05/2022 - 06/2004
9	Heart Failure 01/2022 - 06/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 06/2003
4	Infections 05/2022 - 08/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 07/2010
3	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2017
2	Mycoses (Diseases, Fungus) 05/2022 - 01/2021
2	Leukemia 05/2022 - 01/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
2	Tachycardia (Tachyarrhythmias) 01/2019 - 12/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016 - 02/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Systolic Heart Failure 01/2022
1	Febrile Neutropenia 01/2022
1	Philadelphia Chromosome 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Anemia 01/2019
1	Necrosis 12/2018
1	Aspergillosis 01/2018
1	Mucormycosis 01/2018
1	Critical Illness (Critically Ill) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 12/2012
1	Carcinoma (Carcinomatosis) 12/2012

Drug/Important Bio-Agent (IBA)

33	AnthracyclinesIBA 01/2022 - 09/2002
21	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2002
6	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2012 - 04/2006
5	Pharmaceutical PreparationsIBA 05/2022 - 05/2008
5	Epirubicin (Ellence)FDA LinkGeneric 05/2012 - 06/2004
5	quinone (benzoquinone)IBA 01/2010 - 01/2004
4	Antineoplastic Agents (Antineoplastics)IBA 05/2012 - 06/2004
3	midostaurinIBA 05/2022 - 01/2021
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2018
3	Trastuzumab (Herceptin)FDA Link 04/2019 - 05/2008
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013 - 06/2009
3	adriamycinolIBA 02/2013 - 07/2006
3	hydroquinone (Esoterica)FDA Link 01/2010 - 01/2008
3	IronIBA 01/2008 - 01/2004
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 11/2020
2	Ranolazine FDA Link 01/2022 - 01/2019
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 02/2007
2	pixantrone (BBR 2778)IBA 01/2016 - 02/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2016 - 02/2013
2	AnthraquinonesIBA 01/2016 - 02/2013
2	Superoxides (Superoxide)IBA 02/2013 - 05/2012
2	AntioxidantsIBA 01/2010 - 09/2002
2	Free RadicalsIBA 01/2008 - 06/2004
2	Docetaxel (Taxotere)FDA Link 02/2007 - 07/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 07/2006
2	taxaneIBA 02/2007 - 07/2006
2	ferrylmyoglobinIBA 02/2004 - 09/2002
1	Inotuzumab OzogamicinIBA 01/2022
1	enasidenibIBA 01/2022
1	gilteritinibIBA 01/2022
1	ivosidenibIBA 01/2022
1	olutasidenibIBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	quizartinibIBA 01/2022
1	venetoclaxIBA 01/2022
1	Gemtuzumab (Mylotarg)FDA Link 01/2022
1	glasdegibIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2022
1	Phosphodiesterase InhibitorsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	SodiumIBA 01/2022
1	ponatinibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	Cardiovascular AgentsIBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019
1	TroponinIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2018
1	Troponin IIBA 12/2018
1	Hormones (Hormone)IBA 12/2018
1	AntiemeticsIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2018
1	TriazolesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	isavuconazoleIBA 01/2018
1	Colistin (Coly-Mycin)FDA Link 01/2018
1	isoquinolineIBA 01/2016
1	Ion Channels (Ion Channel)IBA 10/2015

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2022 - 07/2006
11	Therapeutics 11/2020 - 04/2006
2	Biological Therapy 05/2022 - 01/2022
2	Transplantation 05/2022 - 01/2022
2	Drug Tapering 01/2017 - 07/2010
1	Continuous Renal Replacement Therapy 01/2018
1	Induction Chemotherapy 01/2018
1	Secondary Prevention 10/2015
1	Salvage Therapy 02/2013
1	Hyperthermic Intraperitoneal Chemotherapy 12/2012